Kalipso Chalkidou

Mar 9, 2025 | linkedin.com | Kalipso Chalkidou

Punjabi performers at the end of Day 1... Fifteen years ago, Dr Sundararaman, the founding director of India’s National Health Systems Resource Centre, a think tank under the MoHFW, invited me to give a lecture about NICE, the National Health Service’s Health Technology Assessment body. It was one of my first “missions” as the head of 3-person team, NICE International, set up to share experiences on evidence informed policy making with governments around the world.

Mar 6, 2025 | gh.bmj.com | Kalipso Chalkidou |Richard J. Sullivan

Introduction‘[power’s] success is proportional to its ability to hide its own mechanisms’. The lancet commission: Women, power and cancer investigates, exposes and challenges the prevailing asymmetries of power in relation to cancer in three domains: Decision-making, knowledge and economics.

Feb 6, 2025 | devex.com | Kalipso Chalkidou

A recent review of four key climate funds offers a blueprint applicable to the global health financing landscape. In October 2024, Brazil’s G2 Presidency’s Sustainable Finance Working Group published a review of several vertical climate and environmental funds. Authored by independent experts, the report examined four major multilateral funds, offering actionable recommendations to streamline their operations and boost their ability to leverage additional public and private finance.

Sep 27, 2024 | linkedin.com | Kalipso Chalkidou

It is not often that eight major international organisations and 20+ country representatives from government and civil society to mitigate against donor fund volatility and proactively to plan for effective and equitable transitioning away from aid and progressing towards #UHC.

Aug 15, 2024 | reliefweb.int | Kalipso Chalkidou |Victoria Fan

Attachments Download Report (PDF | 1022.73 KB) By Kalipso Chalkidou, Victoria Fan and Clemence LandersThe grants model: how we got hereOver the last twenty plus years, global health has benefited from the emergence of new financing models and “global health initiatives” (GHIs), including Gavi, the Vaccine Alliance and the Global Fund to Fight Aids, Tuberculosis, and Malaria.